Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 4/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | GLA | P06280 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.52 |
| ▸ | CASP1 | P29466 | 1/20 | 0.52 |
| ▸ | CASP7 | P55210 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.51 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.51 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.51 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.51 |
| ▸ | TTR | P02766 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | MGAM | O43451 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9367069 | 0.89 | TDP1 (0.56) | MAOAKDM4EGLAALDH1A1CYP3A4 | |
| SCHEMBL9738575 | 0.87 | MAOA (0.53) | MAOAKDM4EGLAALDH1A1CYP3A4 | |
| SCHEMBL27726953 | 0.86 | MAOA (0.55) | MAOAKDM4EGLAALDH1A1CYP3A4 | |
| SCHEMBL13359234 | 0.83 | MAOA (0.64) | MAOAKDM4EGLAALDH1A1CYP3A4 | |
| SCHEMBL29975151 | 0.83 | KDM4E (0.71) | MAOAKDM4EGLAALDH1A1CYP3A4 | |
| SCHEMBL107952 | 0.83 | KDM4E (0.71) | MAOAKDM4EGLAALDH1A1CYP3A4 | |
| SCHEMBL27860391 | 0.80 | KDM4E (0.56) | MAOAKDM4EGLAALDH1A1CYP3A4 | |
| SCHEMBL8649540 | 0.80 | MAOA (0.46) | MAOAKDM4EGLAALDH1A1CYP3A4 | |
| SCHEMBL18242476 | 0.80 | MAOA (0.59) | MAOAKDM4EGLAALDH1A1CYP3A4 | |
| SCHEMBL5425706 | 0.79 | MAOA (0.54) | MAOAKDM4EGLAALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9855734-B2 | Wafer processing method | SEKISUI CHEMICAL CO., LTD. (JP) | 2018-01-02 | — | — | US | disclosed |
| CN-104520974-B | The processing method of wafer | SEKISUI CHEMICAL CO.,LTD. (JP) | 2016-02-10 | — | — | CN | disclosed |
| US-20150217552-A1 | WAFER PROCESSING METHOD | SEKISUI CHEMICAL CO., LTD. (JP) | 2015-08-06 | — | — | US | disclosed |
| CN-104541356-A | Processing method for wafer | SEKISUI CHEMICAL CO LTD | 2015-04-22 | — | — | CN | disclosed |
| CN-104520974-A | Wafer processing method | SEKISUI CHEMICAL CO LTD | 2015-04-15 | — | — | CN | disclosed |
| US-6514983-B1 | Inhibitors of the nucleic enzyme poly(adenosine 5'-diphospho-ribose)polymerase | GUILFORD PHARMACEUTICALS INC. | 2003-02-04 | — | — | US | disclosed |
| US-6306889-B1 | FUSED HETEROCYCLIC DRUGS FOR CARDIOVASCULAR DISORDERS | GUILFORD PHARMACEUTICALS INC. | 2001-10-23 | — | — | US | disclosed |
| EP-1019409-A1 | POLY(ADP-RIBOSE) POLYMERASE (\"PARP\") INHIBITORS, METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING NEURAL OR CARDIOVASCULAR TISSUE DAMAGE | GUILFORD PHARMACEUTICALS INC. (US) | 2000-07-19 | — | — | EP | disclosed |
| WO-1999011645-A1 | POLY(ADP-RIBOSE) POLYMERASE ('PARP') INHIBITORS, METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING NEURAL OR CARDIOVASCULAR TISSUE DAMAGE | GUILFORD PHARMACEUTICALS INC. (US) | 1999-03-11 | — | — | WO | disclosed |
| EP-0278176-B1 | Compounds having antitumour and antibacterial properties | WARNER LAMBERT CO (US) | 1994-03-09 | — | — | EP | disclosed |
| US-5281620-A | Alkyl substituted xanthenone-4-acetic acid | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1994-01-25 | — | — | US | disclosed |
| EP-0278176-A2 | Compounds having antitumour and antibacterial properties | WARNER-LAMBERT COMPANY (US) | 1988-08-17 | — | — | EP | disclosed |